UPNEEQ is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Rvl Pharmaceuticals, Inc.. The primary component is Oxymetazoline Hydrochloride.
| Product ID | 73687-062_22725084-2f0d-491f-b474-2e9ebb7a470a |
| NDC | 73687-062 |
| Product Type | Human Prescription Drug |
| Proprietary Name | UPNEEQ |
| Generic Name | Oxymetazoline Hydrochloride Ophthalmic |
| Dosage Form | Solution/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2020-08-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212520 |
| Labeler Name | RVL Pharmaceuticals, Inc. |
| Substance Name | OXYMETAZOLINE HYDROCHLORIDE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Vasoconstrictor [EPC],Vasoconstriction [PE],Increased Sympathetic Activity [PE],Imidazolines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-08-21 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() UPNEEQ 90281158 not registered Live/Pending |
RVL Pharmaceuticals, Inc. 2020-10-27 |
![]() UPNEEQ 90244070 not registered Live/Pending |
RVL Pharmaceuticals, Inc. 2020-10-09 |
![]() UPNEEQ 90045944 not registered Live/Pending |
RVL Pharmaceuticals, Inc. 2020-07-10 |
![]() UPNEEQ 88791296 not registered Live/Pending |
Vertical Pharmaceuticals, LLC 2020-02-10 |